MedTrace Logo

The FaibaGo Study - Long-Term Weight Reduction Via Low-Threshold Intervention

NCT07036692 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-11-21

No results posted yet for this study

Summary

The main aim of this study is to assess the effect of a chewing gum containing galactooligosaccharides (GOS) on the body mass index (BMI), the metabolism and the oral and intestinal microbiomes in a population of overweight adults.

Conditions

Interventions

DIETARY_SUPPLEMENT

Placebo

To chew every day during a period of 4 months 3 chewing gums (morning, noon and evening) for at least 20 minutes each.

DIETARY_SUPPLEMENT

FibreGum

To chew every day during a period of 4 months 3 chewing gums (morning, noon and evening) for at least 20 minutes each.

Sponsors & Collaborators

  • DCB Research AG

    collaborator OTHER

  • University of Bern

    lead OTHER

Principal Investigators

  • Maria L Balmer, Prof. med. · Department of Biomedical Research, University of Bern

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-09
Primary Completion
2026-10-31
Completion
2026-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07036692 on ClinicalTrials.gov